An Open-Label Clinical Study Evaluating the Long-Term Sa

Project: Research project

Project Details

Description

An Open-Label Clinical Study Evaluating the Long-Term Safety of ALTU-135 for the Treatment of Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
StatusFinished
Effective start/end date4/1/076/30/09

Funding

  • Altus Pharmaceuticals Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.